| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/25/2010 | US20100075324 Processes for detecting toxic substances |
| 03/25/2010 | US20100075323 Molecular markers for lung and colorectal carcinomas |
| 03/25/2010 | US20100075322 Methods and Compositions for Identifying Mycotoxins and Fungal Species |
| 03/25/2010 | US20100075321 Labeled compound and detection method using the same |
| 03/25/2010 | US20100075320 Paxillin mutations, methods of assessing risk of metastasis and methods of staging tumors |
| 03/25/2010 | US20100075319 Blocking Agents Comprising Non-Natural Nucleic Acids and Detection Methods Using such Blocking Agents |
| 03/25/2010 | US20100075318 Method of determining the haplotype of multiple allelic genes |
| 03/25/2010 | US20100075317 Airborne Particulate Sampler |
| 03/25/2010 | US20100075316 Method for identifying altered vitamin d metabolism |
| 03/25/2010 | US20100075315 Microvesicle-Based Compositions and Methods |
| 03/25/2010 | US20100075314 Chemically-modified gold nanoparticles and methods for use in detecting target molecules |
| 03/25/2010 | US20100075313 Device for the lysis of microorganisms present in an environmental or clinical sample and the extraction of nucleic acids from said microorganisms for analysis |
| 03/25/2010 | US20100075312 Qpcr analysis apparatus |
| 03/25/2010 | US20100075311 Cartridge system |
| 03/25/2010 | US20100075310 Methods for Microorganism Detection and Identification |
| 03/25/2010 | US20100075309 Intermittent detection during analytical reactions |
| 03/25/2010 | US20100075308 Polymorphisms in genes affecting cns disorders and uses thereof |
| 03/25/2010 | US20100075307 Analyte detection assays |
| 03/25/2010 | US20100075306 Method for diagnosis of and following a bacterial vaginosis by molecular quantification |
| 03/25/2010 | US20100075305 Detection of bacterium by utilizing dnaj gene and use thereof |
| 03/25/2010 | US20100075304 Process for monitoring colorectal cancer |
| 03/25/2010 | US20100075303 Methods for targetted mutagenesis in gram-positive bacteria |
| 03/25/2010 | US20100075302 Assays for Resistance to Echinocandin-Class Drugs |
| 03/25/2010 | US20100075301 Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface |
| 03/25/2010 | US20100075300 Arrayed detector system for measurement of anti-viral immune response |
| 03/25/2010 | US20100075299 Detection and use of antiviral resistance mutations |
| 03/25/2010 | US20100075298 Method for rapid identification and quantification of microorganisms |
| 03/25/2010 | US20100075297 Photosensitive polypeptide and methods of their production and use |
| 03/25/2010 | US20100075295 Novel Cellular Compositions and Methods for Their Preparation |
| 03/25/2010 | US20100074962 Degradation of prion protein and reduced prion infectivity by earthworm homogenates |
| 03/25/2010 | US20100074956 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
| 03/25/2010 | US20100074933 Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides |
| 03/25/2010 | US20100074929 Administration of agents mimicking dopachrome tautomerase (trp-2) activity for protecting hair follicle melanocytes |
| 03/25/2010 | US20100074920 Peptide vaccine for influenza virus |
| 03/25/2010 | US20100074914 DNA vaccine comprising CTGF-encoding DNA construct and applications thereof |
| 03/25/2010 | US20100074906 Antibodies Specific for Varicella Zoster Virus |
| 03/25/2010 | US20100074890 Methods for identifying hcv protease inhibitors |
| 03/25/2010 | US20100074888 Animal having modification in mgat2 gene |
| 03/25/2010 | US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases |
| 03/25/2010 | US20100074874 Synthetic multi-layer structures comprising biopolymer fibres |
| 03/25/2010 | US20100074864 Methods and kits for predicting prognosis of multiple sclerosis |
| 03/25/2010 | US20100074843 Novel Substrate Based PET Imaging Agents |
| 03/25/2010 | US20100072064 Subcutaneous Glucose Electrode |
| 03/25/2010 | US20100072063 Subcutaneous Glucose Electrode |
| 03/25/2010 | US20100072062 Membrane For Use With Amperometric Sensors |
| 03/25/2010 | DE102008048605A1 Marking or identifying biomolecule e.g. protein, comprises contacting biomolecule with a complex, preferably chelate complex of an element of rare earth under formation of a bond between biomolecule and the rare earth complex |
| 03/25/2010 | DE102008047689A1 New xanthene derivative useful as a dye in the detection of biomolecules in a sample, preferably useful in the bioanalysis and diagnosis purposes |
| 03/25/2010 | CA2739309A1 Plasmonic electricity |
| 03/25/2010 | CA2738596A1 Selective processing of biological material on a microarray substrate |
| 03/25/2010 | CA2738002A1 Lgr5 modulators in the treatment of alopecia |
| 03/25/2010 | CA2737993A1 Fzd2 modulators in the treatment of alopecia |
| 03/25/2010 | CA2737983A1 Sox modulators in the treatment of alopecia |
| 03/25/2010 | CA2737643A1 Noninvasive diagnosis of fetal aneuploidy by sequencing |
| 03/25/2010 | CA2737551A1 Methods and compositions for the treatment of cancer |
| 03/25/2010 | CA2737486A1 Interferon response in clinical samples (iris) |
| 03/25/2010 | CA2737378A1 Vaccines containing canine parvovirus genetic variants |
| 03/25/2010 | CA2737212A1 Dendritic cell modulatory molecule |
| 03/25/2010 | CA2737200A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| 03/25/2010 | CA2736936A1 Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi) |
| 03/25/2010 | CA2735869A1 Optical method for the detection of alzheimer's disease |
| 03/25/2010 | CA2733653A1 Detection of target variants using a fluorescent label and a soluble quencher |
| 03/25/2010 | CA2729978A1 Methods for identification and prediction of multiple sclerosis disease and therapy response |
| 03/24/2010 | EP2166470A1 Analysis of melt curves, particularly dsDNA and protein melt curves |
| 03/24/2010 | EP2166113A1 Method for detecting, identifying and quantifying Brachyspira and kit for implementing such a method |
| 03/24/2010 | EP2166112A1 Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI) |
| 03/24/2010 | EP2166111A1 Prognostic factor in sarcoma, and metastasis inhibitor |
| 03/24/2010 | EP2166110A1 SCREENING METHOD UTILIZING NOVEL SUBSTRATE EphA4 FOR GAMMA-SECRETASE |
| 03/24/2010 | EP2166017A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 03/24/2010 | EP2165716A1 Novel bone mass increasing agent |
| 03/24/2010 | EP2165194A2 BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNF-alpha INHIBITORS IN AUTOIMMUNE DISORDERS |
| 03/24/2010 | EP2165193A1 Apparatus for monitoring water for microbial germs |
| 03/24/2010 | EP2164997A2 Novel optical labeling molecules in proteomics and other biological analyses |
| 03/24/2010 | EP2164996A2 Riboswitches and methods and compositions for use of and with riboswitches |
| 03/24/2010 | EP2164994A1 Methods and compositions related to riboswitches that control alternative splicing and rna processing |
| 03/24/2010 | EP2164993A2 Methods for production and uses of multipotent cell populations, pluripotent cell populations, differentiated cell populations, and hiv-resistant cell populations |
| 03/24/2010 | EP2164992A1 Compositions and methods for binding lysophosphatidic acid |
| 03/24/2010 | EP2164991A1 Methods, systems, and kits for evaluating multiple sclerosis |
| 03/24/2010 | EP2164990A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| 03/24/2010 | EP2164988A2 Fluorescent methods and materials for directed biomarker signal amplification |
| 03/24/2010 | EP2164987A1 Nucleic acid chip for obtaining bind profile of single strand nucleic acid and unknown biomolecule, manufacturing method thereof and analysis method of unknown biomolecule using nucleic acid chip |
| 03/24/2010 | EP2164985A1 System and meth0d for identification of individual samples from a multiplex mixture |
| 03/24/2010 | EP2164984A2 Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| 03/24/2010 | EP2164983A1 The novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection |
| 03/24/2010 | EP2164982A2 Lipoprotein surfactant |
| 03/24/2010 | EP2164981A1 Analyte determination methods and devices |
| 03/24/2010 | EP2164980A1 Biomarker and method for determining an oxidative stress level |
| 03/24/2010 | EP2164979A2 Biosensor |
| 03/24/2010 | EP2164978A1 Compositions and methods for modulation of adamts13 activity |
| 03/24/2010 | EP2164977A2 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
| 03/24/2010 | EP2164320A2 Cytochrome p450 genes conferring herbicide resistance |
| 03/24/2010 | EP1618367B1 Optical detector for enzyme activation |
| 03/24/2010 | EP1567669B1 Determination of methylation of nucleic acid sequences |
| 03/24/2010 | EP1492805B1 System for tracing animal products |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | CN201427971Y Cell array-type arrangement chip being excited by single-circuit electric signal |
| 03/24/2010 | CN101680905A Protein assay |
| 03/24/2010 | CN101680897A Predicting response to a her dimerisation inhibitor based on low her3 expression |
| 03/24/2010 | CN101680887A Method of determining risk of scoliosis |
| 03/24/2010 | CN101680884A methods for the detection of preeclampsia |
| 03/24/2010 | CN101680875A Strip for an electrochemical meter |